Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-20 2023-11-06 207716
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-11-06 2023-11-24 209348
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2017-05-16 2017-10-05 10403
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-04-30 2021-05-26 138346
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-01-09 2019-03-16 71668
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-03-27 2019-04-26 79583
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-05-15 2019-08-19 84125
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-06-12 2019-08-19 86282
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-09-04 2019-12-19 92981
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-12-22 2024-02-02 214215
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-19 2024-05-03 225761
APO-LATANOPROST 50MCG SOLUTION Resolved 2024-06-20 2024-09-20 231039
APO-LATANOPROST 50MCG SOLUTION Actual shortage 2024-12-12 2025-03-27 245508
APO-LATANOPROST 50MCG SOLUTION Resolved 2022-04-01 2022-09-23 157695
APO-LATANOPROST 50MCG SOLUTION Resolved 2017-03-10 2020-02-13 363
APO-LATANOPROST-TIMOP 5MG 50MCG SOLUTION Resolved 2017-03-13 2018-09-11 739
APO-LEFLUNOMIDE 10MG TABLET Resolved 2017-03-11 2017-05-23 667
APO-LEFLUNOMIDE 10MG TABLET Resolved 2024-01-19 2024-02-09 216659
APO-LEFLUNOMIDE 20MG TABLET Resolved 2024-04-26 2024-05-31 226315

Showing 1561 to 1580 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750

Showing 261 to 280 of 359